Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Blood Neoplasia |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950328024000645 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832582116418781184 |
|---|---|
| author | Ramsay Hafer Francesco Iadevaia Thomas Z. Rohan Teresa Duong Maria Poluch Gina Keiffer Michael Li Andres Ferber Luca Laurenti Alan S. Khoo Pierluigi Porcu |
| author_facet | Ramsay Hafer Francesco Iadevaia Thomas Z. Rohan Teresa Duong Maria Poluch Gina Keiffer Michael Li Andres Ferber Luca Laurenti Alan S. Khoo Pierluigi Porcu |
| author_sort | Ramsay Hafer |
| collection | DOAJ |
| format | Article |
| id | doaj-art-ac9228fe248342b482bfe87dadfb61b1 |
| institution | Kabale University |
| issn | 2950-3280 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Blood Neoplasia |
| spelling | doaj-art-ac9228fe248342b482bfe87dadfb61b12025-01-30T05:15:23ZengElsevierBlood Neoplasia2950-32802025-02-0121100064Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaRamsay Hafer0Francesco Iadevaia1Thomas Z. Rohan2Teresa Duong3Maria Poluch4Gina Keiffer5Michael Li6Andres Ferber7Luca Laurenti8Alan S. Khoo9Pierluigi Porcu10Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA; Correspondence: Ramsay Hafer, 21 Longknoll Way, Kingsville, MD 21087;Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University of Sacred Heart, Rome, ItalySidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PASidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PASidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PASidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PACenter for Digital Health & Data Science, Thomas Jefferson University, Philadelphia, PADepartment of Medical Oncology, Thomas Jefferson University, Philadelphia, PASection of Hematology, Department of Radiological and Hematological Sciences, Catholic University of Sacred Heart, Rome, ItalyDepartment of Medical Oncology, Thomas Jefferson University, Philadelphia, PASidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA; Pierluigi Porcu, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut St, Suite 320, Philadelphia, PA 19017;http://www.sciencedirect.com/science/article/pii/S2950328024000645 |
| spellingShingle | Ramsay Hafer Francesco Iadevaia Thomas Z. Rohan Teresa Duong Maria Poluch Gina Keiffer Michael Li Andres Ferber Luca Laurenti Alan S. Khoo Pierluigi Porcu Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma Blood Neoplasia |
| title | Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma |
| title_full | Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma |
| title_fullStr | Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma |
| title_full_unstemmed | Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma |
| title_short | Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma |
| title_sort | real world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia small lymphocytic lymphoma |
| url | http://www.sciencedirect.com/science/article/pii/S2950328024000645 |
| work_keys_str_mv | AT ramsayhafer realworldsafetyprofileoftherapywithibrutiniboracalabrutinibinpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphoma AT francescoiadevaia realworldsafetyprofileoftherapywithibrutiniboracalabrutinibinpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphoma AT thomaszrohan realworldsafetyprofileoftherapywithibrutiniboracalabrutinibinpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphoma AT teresaduong realworldsafetyprofileoftherapywithibrutiniboracalabrutinibinpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphoma AT mariapoluch realworldsafetyprofileoftherapywithibrutiniboracalabrutinibinpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphoma AT ginakeiffer realworldsafetyprofileoftherapywithibrutiniboracalabrutinibinpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphoma AT michaelli realworldsafetyprofileoftherapywithibrutiniboracalabrutinibinpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphoma AT andresferber realworldsafetyprofileoftherapywithibrutiniboracalabrutinibinpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphoma AT lucalaurenti realworldsafetyprofileoftherapywithibrutiniboracalabrutinibinpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphoma AT alanskhoo realworldsafetyprofileoftherapywithibrutiniboracalabrutinibinpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphoma AT pierluigiporcu realworldsafetyprofileoftherapywithibrutiniboracalabrutinibinpatientswithchroniclymphocyticleukemiasmalllymphocyticlymphoma |